Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
CYTOVENE CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 500MG Updated Report 2023-03-31 184528
ONE-ALPHA CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 2MCG Updated Report 2023-03-31 180961
KEVZARA SANOFI-AVENTIS CANADA INC Anticipated shortage 200MG New Report 2023-03-31 188465
FLAGYL SANOFI-AVENTIS CANADA INC Resolved 10% Updated Report 2023-03-31 186612
!!T3 FLUDARA SANOFI-AVENTIS CANADA INC Actual shortage 10MG Updated Report 2023-03-31 167783
GLUCOPHAGE SANOFI-AVENTIS CANADA INC Actual shortage 850MG Updated Report 2023-03-31 178385
METHOTREXATE INJECTION USP PFIZER CANADA ULC Anticipated shortage 25MG Updated Report 2023-03-31 188454
DEXTROSE INJECTION OMEGA LABORATORIES LIMITED Actual shortage 50% Updated Report 2023-03-31 182591
DILTIAZEM HYDROCHLORIDE INJECTION OMEGA LABORATORIES LIMITED Actual shortage 5MG Updated Report 2023-03-31 187972
RIVOTRIL CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 0.5MG Updated Report 2023-03-31 171577
RIVOTRIL CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 2MG Updated Report 2023-03-31 171580
DIPENTUM ATNAHS PHARMA UK LIMITED Actual shortage 250MG Updated Report 2023-03-31 188443
DEXAMETHASONE OMEGA UNIDOSE OMEGA LABORATORIES LIMITED Resolved 10MG Updated Report 2023-03-31 187964
IMITREX GLAXOSMITHKLINE INC Resolved 6MG Updated Report 2023-03-31 179840
IPRAVENT AA PHARMA INC Resolved 42MCG Updated Report 2023-03-31 186512
SYNJARDY BOEHRINGER INGELHEIM (CANADA) LTD LTEE Actual shortage 500MG 12.5MG Updated Report 2023-03-31 187797
KETOROLAC AA PHARMA INC Actual shortage 0.5% Updated Report 2023-03-31 188326
MISOPROSTOL AA PHARMA INC Actual shortage 100MCG Updated Report 2023-03-31 188329
0.9% SODIUM CHLORIDE IRRIGATION, USP BAXTER CORPORATION Resolved 900MG Updated Report 2023-03-31 181191
0.9% SODIUM CHLORIDE IRRIGATION, USP BAXTER CORPORATION Resolved 900MG Updated Report 2023-03-31 181393
5% DEXTROSE INJECTION, USP BAXTER CORPORATION Resolved 5G Updated Report 2023-03-31 187084
FOQUEST ELVIUM LIFE SCIENCES Actual shortage 55MG Updated Report 2023-03-31 188286
APO-ESOMEPRAZOLE APOTEX INC Actual shortage 40MG Updated Report 2023-03-30 188427
APO-ALLOPURINOL APOTEX INC Actual shortage 200MG New Report 2023-03-30 188424
APO-ZOPICLONE APOTEX INC Actual shortage 7.5MG New Report 2023-03-30 188421
APO PREDNISONE TAB 50MG APOTEX INC Actual shortage 50MG New Report 2023-03-30 188418
APO-SITAGLIPTIN MALATE APOTEX INC Actual shortage 50MG Updated Report 2023-03-30 188415
APO-SITAGLIPTIN MALATE APOTEX INC Actual shortage 100MG Updated Report 2023-03-30 188411
APO-SITAGLIPTIN/METFORMIN XR APOTEX INC Actual shortage 1000MG 50MG Updated Report 2023-03-30 185982
APO-SITAGLIPTIN/METFORMIN XR APOTEX INC Actual shortage 1000MG 50MG Updated Report 2023-03-30 185976
APO-SITAGLIPTIN/METFORMIN XR APOTEX INC Actual shortage 1000MG 50MG Updated Report 2023-03-30 185973
APO-SITAGLIPTIN/METFORMIN XR APOTEX INC Actual shortage 500MG 50MG Updated Report 2023-03-30 185970
APO-SITAGLIPTIN MALATE APOTEX INC Actual shortage 25MG Updated Report 2023-03-30 184112
APO-SITAGLIPTIN/METFORMIN XR APOTEX INC Actual shortage 1000MG 100MG Updated Report 2023-03-30 185985
APO-SITAGLIPTIN/METFORMIN XR APOTEX INC Actual shortage 1000MG 100MG Updated Report 2023-03-30 185967
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE APOTEX INC Actual shortage 1000MG 50MG Updated Report 2023-03-30 185964
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE APOTEX INC Actual shortage 1000MG 50MG Updated Report 2023-03-30 185961
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE APOTEX INC Actual shortage 1000MG 50MG Updated Report 2023-03-30 185957
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE APOTEX INC Actual shortage 850MG 50MG Updated Report 2023-03-30 185954
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE APOTEX INC Actual shortage 850MG 50MG Updated Report 2023-03-30 185951
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE APOTEX INC Actual shortage 500MG 50MG Updated Report 2023-03-30 180124
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE APOTEX INC Actual shortage 500MG 50MG Updated Report 2023-03-30 185948
APO-RASAGILINE APOTEX INC Actual shortage 1MG Updated Report 2023-03-30 187244
APO-SOTALOL APOTEX INC Actual shortage 160MG Updated Report 2023-03-30 186569
APO-NAPROXEN APOTEX INC Actual shortage 500MG Updated Report 2023-03-30 185459
APO-OLANZAPINE APOTEX INC Actual shortage 20MG Updated Report 2023-03-30 184097
APO-OXYBUTYNIN APOTEX INC Actual shortage 5MG Updated Report 2023-03-30 183474
APO-OXYBUTYNIN APOTEX INC Actual shortage 5MG Updated Report 2023-03-30 187229
TRI-CIRA LO 21 APOTEX INC Actual shortage 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG Updated Report 2023-03-30 172942
APO-RALOXIFENE APOTEX INC Actual shortage 60MG Updated Report 2023-03-30 181104

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
HIBERIX GLAXOSMITHKLINE INC Discontinued 10MCG Updated Report 2023-03-29 175258
OMNISCAN GE HEALTHCARE CANADA INC Discontinued 287MG Updated Report 2023-03-25 182742
QUININE - ODAN ODAN LABORATORIES LTD Discontinued 200MG New Report 2023-03-22 187637
FLAGYL ODAN LABORATORIES LTD Discontinued 500MG New Report 2023-03-22 187634
NOLVADEX-D TAB 20MG ASTRAZENECA CANADA INC Discontinued 20MG Updated Report 2023-03-22 170947
OMNIPAQUE 240 GE HEALTHCARE CANADA INC Discontinued 518MG Updated Report 2023-03-18 182760
GLUCAGON ELI LILLY CANADA INC To be discontinued 1MG Updated Report 2023-03-14 165759
ZOFRAN ODT NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 4MG New Report 2023-03-14 187062
ZOFRAN ODT NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 8MG Updated Report 2023-03-14 177540
STRATTERA ELI LILLY CANADA INC To be discontinued 40MG Updated Report 2023-03-01 171488